CD274 and esophageal squamous cell carcinoma: A study conducted by Lim et al. (2016) supports this notion, as it observed a significant increase in PD-L1 expression (p = 0.007) in locally advanced esophageal squamous cell carcinoma (ESCC) patients after neoadjuvant chemoradiotherapy, highlighting the potential of this combination therapy.